Zinacef
NDC Package 24987-352-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Zinacef is cefuroxime is used to treat a wide variety of bacterial infections. Marketed by Covis Pharmaceuticals Inc, this product is identified by NDC 24987-352 and is authorized under FDA application NDA050558.

Identification & Billing

NDC Package Code
24987-352-10
Package Description
10 VIAL in 1 TRAY / 8.3 mL in 1 VIAL
Product Code
24987-352
11-Digit Billing Format
24987035210
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Zinacef
Dosage Form
-
Usage Information
Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Covis Pharmaceuticals Inc
FDA Application #
NDA050558
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-15-2013
End Marketing Date
07-07-2017
Listing Expiration
07-07-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24987-352-10 identifies a specific commercial package of 10 vial in 1 tray / 8.3 ml in 1 vial of Zinacef, labeled by Covis Pharmaceuticals Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Covis Pharmaceuticals Inc on January 15, 2013. The current certification is valid through July 07, 2017.

What are the primary indications for this medication?

Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

How is this Covis Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24987035210. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24987-352-10
11-Digit CMS (5-4-2)
24987-0352-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.